- JNJ -0.26%
Johnson & Johnson (JNJ): A Cheap Pharmaceutical Stock to Buy According to Short Sellers
Yahoo Finance · 6 hours ago
Open | 163.50 |
High | 164.04 |
Low | 162.16 |
Mkt Cap | 392.26B |
P/E (TTM) | 24.61 |
Div & Yield | 4.96 & 3.04% |
Prev. Close | 163.37 |
52 Wk. Low | 143.13 |
52 Wk. High | 165.83 |
Related stocks
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Wikipedia
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 22.45B | 4.30% ▲ |
Net Income | 4.69B | 8.90% ▼ |
Diluted EPS | 2.82 | 1.60% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q3 2024 | $2.18 | - |
Q2 2024 | $2.70 | $2.82 |
Q1 2024 | $2.64 | $2.71 |
S&P FuturesES=F | 5,644.50-0.25 (-0.00%) |
Dow FuturesYM=F | 41,371.00+15.00 (+0.04%) |
Nasdaq FuturesNQ=F | 19,641.00-12.75 (-0.06%) |
128.30+1.46% | |
Bitcoin USDBTC-USD | 59,047.82-6.14% |
9.45-8.96% |